Skip to content

Reducing Length of Stay for Veterans Hospitalized With Pneumonia

Reducing Length of Stay for Veterans Hospitalized With Pneumonia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01068548
Enrollment
129
Registered
2010-02-15
Start date
2011-02-28
Completion date
2011-11-30
Last updated
2019-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pneumonia

Brief summary

This is a pilot study to implement a computer based intervention to safely reduce length of hospital stay and time to conversion to oral antibiotics for patients with pneumonia.

Detailed description

Pneumonia is the 3rd leading medical discharge diagnosis in the VA, and although significant attention has been focused improving pneumonia process of care measures less attention has been paid to resource use, specifically length of hospital stay (LOS). Based on our preliminary analyses LOS is considerably higher in the VA versus other non-federal hospitals. Major causes of this increased length of stay are delayed conversion from intravenous (IV) to oral therapy upon reaching clinical stability, and not discharging on the same day as the conversion to oral antibiotics. Therefore additional interventions are needed to decrease the LOS for veterans hospitalized with pneumonia in the VA system. The long-term goal of this research is to develop sustainable approaches to reduce LOS and thereby improve efficiency of care in veterans admitted with pneumonia to VA Medical Centers through the implementation of computerized clinical stability reminders. Although prior research, including our own, has demonstrated moderate effectiveness of resource intense methods to implement this criteria (e.g., utilization management nurses) new, more effective and less resource intense, strategies are needed to accomplish this long-term goal. The design of the computerized clinical stability reminder, the likely range in magnitude of response to implementation of the intervention, logistics of data collection, data management, and development of study instruments are needed prior to commencement of a more definitive, multi-center study. Hence, we are seeking funding to conduct the necessary pilot work needed to successfully design and implement a large multi-center randomized intervention study to reduce LOS for veterans with pneumonia. Our objectives include: 1) Develop and perform a local pilot implementation of an inpatient clinical reminder within Computerized Patient Record System to identify when veterans hospitalized with pneumonia are clinically stable and ready for conversion form IV to oral antibiotic therapy and hospital discharge. 2) Test measures of the constructs of the Theory of Planned Behavior (TPB) in VA medicine ward physicians and determine if they correlate with intention and discharge behavior. 3) Establish a collaborative of VA Medical Centers for the purpose of developing a larger scale implementation study to use evidence-based criteria to reduce LOS for patients hospitalized with pneumonia. 4) Prepare a VA HSR&D IIR grant proposal for a cluster randomized controlled trial of a clinical reminder intervention to reduce length of hospital stay among veterans hospitalized with pneumonia. The proposed pilot study will develop and implement a computerized-based inpatient clinical reminder to assist physicians with appropriate conversion from IV to oral antibiotics and discharge on the same day for veterans hospitalized with pneumonia. In addition to creating and implementing the clinical reminder at single tertiary care VA teaching hospital, we will examine physician attitudes and potential barriers/facilitators to the introduction of inpatient clinical reminders using the theoretical model of TPB. We will also assemble a cohort of VA medical centers with investigators and chiefs of medical staff willing to participate in a multi-center randomized control trial of this intervention. The results from this pilot study will be used to plan a larger, more definitive multi-center trial of this inpatient clinical reminder with the goal of significantly reducing LOS for veterans hospitalized with pneumonia in the VA health care system.

Interventions

OTHERreminder

computer based reminder to change patients from IV to oral antibiotics based on evidence based clinical practice guidelines

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient hospitalized with outpatient-acquired pneumonia at South Texas Veterans Health Care System during study period.

Exclusion criteria

none

Design outcomes

Primary

MeasureTime frame
Length of Hospital Stay1 month

Secondary

MeasureTime frame
Time to Change to Oral Antibiotics1 month

Countries

United States

Participant flow

Participants by arm

ArmCount
Arm 1
pre-implementation of computer based intervention
66
Arm 2
post-implementation of computer based intervention reminder: computer based reminder to change patients from IV to oral antibiotics based on evidence based clinical practice guidelines
63
Total129

Baseline characteristics

CharacteristicArm 1Arm 2Total
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
40 Participants39 Participants79 Participants
Age, Categorical
Between 18 and 65 years
26 Participants24 Participants50 Participants
Age, Continuous70.1 years
STANDARD_DEVIATION 13.2
69.2 years
STANDARD_DEVIATION 12.4
69.7 years
STANDARD_DEVIATION 12.8
Region of Enrollment
United States
66 participants63 participants129 participants
Sex: Female, Male
Female
2 Participants3 Participants5 Participants
Sex: Female, Male
Male
64 Participants60 Participants124 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 660 / 63
serious
Total, serious adverse events
0 / 660 / 63

Outcome results

Primary

Length of Hospital Stay

Time frame: 1 month

ArmMeasureValue (MEAN)Dispersion
Arm 1Length of Hospital Stay7.3 DaysStandard Deviation 7
Arm 2Length of Hospital Stay5.8 DaysStandard Deviation 4.7
Secondary

Time to Change to Oral Antibiotics

Time frame: 1 month

Population: PI has left the VA and is not able to determine if data were collected.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026